Myron Kaplan - May 18, 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Director
Signature: /s/ Myron Kaplan
Stock symbol: CRMD
Transactions as of: May 18, 2023
Transactions value $: $27,258
Form type: 4
Date filed: 5/19/2023, 04:02 PM
Previous filing: Jan 18, 2023
Next filing: Mar 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Purchase	$27.3K	+6K	+3.75%	$4.54	166K	May 18, 2023	Direct	F1
holding	CRMD	Common Stock						20K	May 18, 2023	Spouse	F2
holding	CRMD	Common Stock						10K	May 18, 2023	Spouse as Guardian for Grandchildren	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.53 to $4.55, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2	The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.53 to $4.55, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.